Biotech News
Related news
IARTIntegra LifeSciences2026-09-04 13:15 EST
Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference
SGHTSight Sciences2026-09-01 20:05 EST
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15
ICUSeaStar Medical2026-09-29 12:36 EST
SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026
TMCITreace Medical Concepts2026-09-17 21:16 EST
Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
OTLKOutlook2026-08-27 13:01 EST
Outlook Therapeutics CEO, Bob Jahr, Participates in the Virtual Investor “Why Now” On-Demand Conference
ICUSeaStar Medical2026-09-10 12:35 EST
SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference
TARSTarsus Pharmaceuticals2026-09-01 20:30 EST
Tarsus to Participate in Upcoming Investor Conferences
ADPTAdaptive Biotechnologies2026-09-01 20:05 EST
Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
RXSTRxSight2026-08-26 20:15 EST
RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
IRIXIRIDEX2026-10-05 11:00 EST
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
IRIDEX
Ophthalmic Laser Technology Company Iridex develops, manufactures, and markets laser-based medical systems, delivery devices, and accessories for ophthalmology. Its products are used by eye-care specialists to treat glaucoma, diabetic macular edema, and other retinal diseases. MicroPulse Technology The company's proprietary MicroPulse...
Recent company news
IRIXIRIDEX2026-10-05 11:00 EST
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
IRIXIRIDEX2026-08-18 20:05 EST
Iridex Reports Second Quarter 2026 Financial Results
IRIXIRIDEX2026-08-04 20:05 EST
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
IRIXIRIDEX2026-07-20 11:00 EST
Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
IRIXIRIDEX2026-06-09 20:05 EST
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
Stock data
- Close
- 0.68 USD
- Market cap
- 20.37M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States